{
    "nct_id": "NCT05283629",
    "official_title": "Neuroplasticity-Based Cognitive Remediation for Chemotherapy Related Cognitive Impairment Randomized Study",
    "inclusion_criteria": "All participants will:\n\n* between 35 and 80 years of age\n* have been diagnosed with noninvasive or invasive breast cancer\n* have undergone treatment with systemic chemotherapy within the last 1- 8 years\n* endorse persistent CRCI subjective complaints\n* have no active unstable medical condition\n* fluent in and able to read English.\nHealthy volunteers allowed\nMust have minimum age of 35 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "Participants will be excluded for\n\n* any active neurologic or untreated/non-remitted psychiatric disease, (e.g. active major depression or another major psychiatric disorder as described in DSM-5)\n* clinically significant cognitive impairment identified on cognitive screening, diagnosis of mild cognitive impairment or dementia\n* history of significant head trauma followed by persistent neurologic deficits\n* history of alcohol or substance abuse or dependence within the past 2 years (DSM-5 criteria)\n* any significant systemic illness or unstable medical condition which could lead to difficulty complying with the protocol\n* Use of any investigational drugs within 30 days or 5 half-lives, whichever is longer, prior to screening\n* red-green color blindness\n* Use of certain CNS active medications (e.g. antidepressants) will be permitted, provided dosing has been stable for at least 3 months.",
    "miscellaneous_criteria": ""
}